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Introduction
The intestinal epithelium is a highly dynamic tissue with con-
tinuous proliferation, migration, differentiation, and apoptosis, 
resulting in complete renewal every 2–7 d, in a spatially and 
temporally organized manner. This process is coordinated by a 
small number of highly conserved signaling pathways (Sancho 
et al., 2004). While migrating toward the villi, progenitor cells 
differentiate into distinct cell types that can be identified using 
morphological criteria and through expression of specific genes. 
Differentiated epithelial cells belong to two classes: absorptive 
enterocytes and secretory cells. Secretory cells can be further 
subdivided  into  three  cell  types:  mucus-producing  goblet   
cells, hormone-secreting enteroendocrine cells, and bactericidal 
Paneth cells.
The composition of the villus epithelium mainly results 
from the interaction of signaling pathways that are active in 
crypt stem and progenitor cells. The most studied examples are 
the Wingless-related MMTV integration site (Wnt) and Notch 
pathways. Inhibition of the Wnt signaling pathway induces a 
complete loss of crypt epithelial progenitors (Korinek et al., 
1998; Pinto et al., 2003). Genetic and pharmacologic inhibition 
of the Notch pathway drives the cells toward a secretory fate, 
T
he unique morphology of tuft cells was first revealed 
by electron microscopy analyses in several endoderm-
derived epithelia. Here, we explore the relationship 
of these cells with the other cell types of the intestinal epi-
thelium and describe the first marker signature allowing 
their unambiguous identification. We demonstrate that al-
though mature tuft cells express DCLK1, a putative marker 
of quiescent stem cells, they are post-mitotic, short lived, 
derive from Lgr5-expressing epithelial stem cells, and are 
found in mouse and human tumors. We show that whereas 
the ATOH1/MATH1 transcription factor is essential for 
their differentiation, Neurog3, SOX9, GFI1, and SPDEF 
are dispensable, which distinguishes these cells from 
enteroendocrine, Paneth, and goblet cells, and raises 
from three to four the number of secretory cell types in the 
intestinal epithelium. Moreover, we show that tuft cells are 
the main source of endogenous intestinal opioids and 
are the only epithelial cells that express cyclooxygenase 
enzymes, suggesting important roles for these cells in the 
intestinal epithelium physiopathology.
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cell population in the intestinal epithelium is still a matter of 
debate. For instance, we have recently demonstrated that the 
solitary cells expressing the doublecortin-like kinase 1 protein 
(DCLK1, also called DCAMKL1), which have been considered 
as putative quiescent stem cells (Giannakis et al., 2006; May   
et al., 2008, 2009; Dekaney et al., 2009; Jin et al., 2009; Sureban 
et al., 2009), are bona fide tuft cells (Gerbe et al., 2009). Since 
their first identification in the rat trachea (Rhodin and Dalhamn, 
1956) and mouse gastrointestinal tract (Jarvi and Keyrilainen, 
1956), tuft cells (also known as brush cells) have been found in 
several endoderm-derived epithelia. These cells are character-
ized by long and blunt microvilli with prominent rootlets, and 
by a well-developed tubulovesicular system in the supranuclear 
cytoplasm (Sato, 2007). Several markers have been proposed 
for tuft cells, including villin, fimbrin (Höfer and Drenckhahn, 
1992), neuronal nitric oxyde synthase (Kugler et al., 1994),   
-gustducin (Höfer et al., 1996), Ulex europaeus lectin 1   
(Gebhard and Gebert, 1999; Gebert et al., 2000), Cytokeratin 18 
(Höfer and Drenckhahn, 1996), and the transient receptor poten-
tial cation channel, subfamily M, member 5 (TRPM5; Bezençon   
et al., 2007). However, due to their ubiquitous expression in the 
intestinal epithelium, villin and fimbrin are not very suitable 
markers of intestinal tuft cells (Höfer and Drenckhahn, 1996). 
Similarly, -gustducin, Trpm5, and Ulex europaeus lectin 1 ex-
pression have also been reported in subtypes of enteroendocrine 
cells (Jang et al., 2007; Sutherland et al., 2007; Bezençon et al., 
2008; Kokrashvili et al., 2009). Finally, the high neuronal nitric 
oxyde synthase expression reported for stomachal and pancre-
atic tuft cells (Kugler et al., 1994) is not a property of intestinal 
tuft cells (Sutherland et al., 2007), and the validity of Cytokera-
tin 18 as a marker for mouse intestinal tuft cells is controversial 
(Gebert et al., 2000). Thus, none of the above markers is strictly 
tuft cell specific and, more than 50 years after their initial dis-
covery, functional studies of tuft cells are still nonexistent. Here, 
we report a marker signature that allows unambiguous identifi-
cation of mouse and human tuft cells, both in the small and 
large intestines. We extend our previous study to demonstrate 
that DCLK1-expressing tuft cells are short lived, post-mitotic 
cells that are permanently generated from Lgr5-expressing stem 
cells. Furthermore, unlike what is commonly thought, we show 
that tuft cells do not belong to the enteroendocrine lineage, but 
rather constitute a distinct entity with transcription factor re-
quirements for differentiation that differ from those of entero-
cytes, enteroendocrine, Paneth, and goblet cells.
Results
A set of molecular markers allows 
unambiguous identification of tuft cells in 
the mouse intestinal epithelium
Trpm5-expressing cells, hypothesized to be tuft cells, were pre-
viously shown to express the cyclooxygenase 1 and 2 (COX1 and 
COX2) enzymes (Bezençon et al., 2008), and we recently found 
that expression of the DCLK1 protein is a specific marker of tuft 
cells (Gerbe et al., 2009). We have now extended these observa-
tions with multiple costaining experiments of the mouse small 
intestinal epithelium, based on previously published micro-array 
even though the Wnt cascade remains active (Fre et al., 2005; 
van Es et al., 2005b) and, accordingly, deletion of the Notch   
effector hairy/enhancer of split 1 (Hes1) results in the generation 
of excessive numbers of goblet, enteroendocrine, and Paneth 
cells (Jensen et al., 2000; Suzuki et al., 2005). Conversely, 
the basic-helix-loop-helix transcription factor encoded by the 
Atonal homologue 1 gene (Atoh1, also called Math1), which is 
repressed by the HES1 transcription factor, is required for a pro-
genitor cell to adopt a secretory fate (Yang et al., 2001; Shroyer 
et al., 2007; van Es et al., 2010). It is often thought that a single 
Atoh1-dependent secretory progenitor exists for all three secre-
tory cell types. However, some data instead point toward the ex-
istence of several bi-potential progenitors that can each produce 
either an enterocyte or a secretory cell belonging to the goblet, 
enteroendocrine, or Paneth cell type, a fate choice that likely re-
lies on Notch signaling (Bjerknes and Cheng, 1999). In addition 
to ATOH1, a set of transcription factors determines the cell fate 
choice and differentiation toward goblet, Paneth, or enteroendo-
crine cell types. Neurogenin 3 (Neurog3, also called Ngn3) is 
essential for all intestinal enteroendocrine cells (Jenny et al., 
2002; Mellitzer et al., 2010) and has been reported to be re-
pressed by the growth factor-independent 1 (GFI1) transcrip-
tion factor, which is normally expressed in both Paneth and 
goblet cells (Bjerknes and Cheng, 2010). Deletion of the Gfi1 
gene, in turn, results in an increased enteroendocrine cell popu-
lation at the expense of Paneth and goblet cells (Shroyer et al., 
2005), likely due to cellular reprogramming of Paneth and gob-
let  cells  toward  a  Neurog3
+  enteroendocrine  cell  phenotype 
(Bjerknes and Cheng, 2010). The Kruppel-like factor 4 (Klf4) 
and SAM pointed domain containing Ets transcription factor 
(Spdef) genes are required for terminal differentiation of goblet 
cells (Katz et al., 2002). Spdef is necessary for Paneth cell matu-
ration (Gregorieff et al., 2009), and differentiation is shifted   
toward the goblet cell type, at the expense of the absorptive as 
well as Paneth and enteroendocrine cell types in the intestinal 
epithelium of transgenic animals overexpressing Spdef (Noah   
et al., 2010). Finally, the SRY-box containing gene 9 (Sox9) is 
essential for differentiation of Paneth cells (Bastide et al., 2007; 
Mori-Akiyama  et  al.,  2007),  and Wnt  signaling  through  the 
Frizzled-5  receptor  is  required  for  their  terminal  maturation 
(van Es et al., 2005a).
The permanent turnover of the intestinal epithelium relies 
on the self-renewing capacity of stem cells. The Wnt target gene 
Leucine-rich repeat containing G protein–coupled receptor 5 
(Lgr5) has been identified as a marker of crypt base columnar 
(CBC) cells (Barker et al., 2007). Genetic lineage-tracing ex-
periments revealed that CBC cells are multipotent and self- 
renewing, thus representing genuine intestinal stem cells (Bjerknes 
and Cheng, 1999; Barker et al., 2007). In addition, cells located 
above the Paneth cell compartment (also known as the +4 posi-
tion) and expressing the Bmi1 polycomb ring finger oncogene 
(Bmi1) have been reported to have features of stem cells (Sangiorgi 
and Capecchi, 2008). However, the presence of these cells is 
limited to the duodenum, and recent studies showed that Bmi1 
expression is, at least partially, overlapping with Lgr5 expres-
sion (van der Flier et al., 2009). Both Lgr5
+ and Bmi1
+ cells are 
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(Giannakis et al., 2006; May et al., 2009), that DCLK1
+ cells 
are never observed in a proliferative state. We further confirm 
this using the proliferating cell nuclear antigen (PCNA; Fig. 2 A), 
and Ki67 or phospho-histone H3 (Fig. S1 D) as proliferation 
markers (n > 200 cells). Furthermore, DCLK1-expressing cells 
express typical tuft cell markers (Gerbe et al., 2009). Yet, the 
possibility existed that we had overlooked a second, nontuft 
fraction of DCLK1
+ cells, which might represent quiescent stem 
cells. To clarify this important point we first compared the level 
of DCLK1 expression with that of other tuft cell markers and 
found that 98.1% of DCLK1
+ cells were COX1
+ (n = 253), the 
rare DCLK1
+ COX1
 cells being mainly found in the lower half 
of the crypts. To further characterize these DCLK1
+ COX1
 
cells present in crypt bottoms, we exploited one of the unique 
morphological features of tuft cells that is not found in other 
epithelial cells: the axial bundles of actin filaments supporting 
the microvilli (Höfer and Drenckhahn, 1998), which can be vi-
sualized with phalloidin. An intense, apical staining of F-actin 
with phalloidin was found in 100% of DCLK1
+ tuft cells pres-
ent in crypt bottoms (n = 74). In addition, we found that SOX9 
expression is higher in tuft cells present in crypt bottoms than in 
Paneth  or  CBC  stem  cells. This  demonstrates  that  although 
COX1 is barely detectable in differentiating tuft cells, strong 
SOX9 expression or the pattern of actin filaments unambigu-
ously identify all DCLK1-expressing cells as tuft cells.
DCLK1
+ tuft cells are postmitotic and 
undergo permanent turnover fueled by 
Lgr5-expressing CBC stem cells
If all DCLK1-expressing cells are indeed differentiated cells, 
we would expect them to have a turnover rate similar to that of 
the other cell types of the intestinal epithelium, and, like other 
intestinal epithelial cell types, they should originate from Lgr5
+ 
CBC stem cells. To measure their turnover rate, we birth-dated 
the DCLK1
+ tuft cell population with BrdU. Wild-type C57BL/6 
mice were treated with BrdU in drinking water for 1 or 2 wk. 
After 1 wk of BrdU treatment, we found that 96% DCLK1
+ 
crypt tuft cells were BrdU
+. This proportion reached 100% after 
2 wk of BrdU treatment (Fig. 2 B). After 2 wk of BrdU treat-
ment, 93% and 100% of tuft cells were BrdU
 after 1 and 2 wk 
of chase with normal drinking water, respectively (Fig. 2 B). 
Therefore, DCLK1
+ tuft cells are not quiescent stem cells but 
instead are postmitotic, short-lived differentiated cells, and their 
turnover time is close to 7 d.
We then performed a lineage tracing experiment using the 
Lgr5
-EGFP-IRES-CreERT2;Rosa26-LacZ compound knock-in mouse 
line, in which the expression of the LacZ reporter gene is pre-
vented by a stop cassette flanked by LoxP sequences (Barker et al., 
2007). Upon tamoxifen injection, CRE activity is induced in Lgr5
+ 
stem cells and the stop cassette is excised, leading to permanent 
LacZ expression in the progeny of recombined Lgr5-expressing 
CBC stem cells. Of note, the intrinsically mosaic Cre expres-
sion in intestinal crypts of Lgr5
-EGFP-IRES-CreERT2;Rosa26-LacZ 
mice results in a mosaic pattern of -galactosidase in the corre-
sponding villi (Fig. 3 A). If tuft cells originate from Lgr5- 
expressing stem cells, we would expect that the proportion   
of total -galacosidase
+ epithelial cells is identical to that of 
data (Bezençon et al., 2008). This allows us to identify a unique 
marker signature of tuft cells, which includes coexpression of 
SOX9, COX1, COX2, hematopoietic prostaglandin-D synthase 
(HPGDS), and DCLK1 (Fig. 1, A–C and F). Compared with 
other  epithelial  cells,  cells  displaying  this  signature  show  a 
stronger immunoreactivity toward villin, -tubulin and F-actin, 
which is a typical feature of tuft cells (Höfer and Drenckhahn, 
1996; Fig. 1, D, E, and G). The SOX9–COX1 or the HPGDS–
COX1 limited signature allowed unambiguous identification of 
tuft cells in the mouse and human colon, as well as in other epi-
thelia such as in the mouse gall bladder (Fig. S1, A–C).
All DCLK1
+ cells are post mitotic tuft cells
Because DCLK1-expressing cells lack differentiation markers 
typical of the other intestinal epithelial cells, and do not prolif-
erate, DCLK1 has been considered as a marker of putative qui-
escent intestinal epithelial stem cells (Giannakis et al., 2006; 
May et al., 2008, 2009; Dekaney et al., 2009; Jin et al., 2009; 
Sureban et al., 2009). We previously reported, like others 
Figure 1.  Molecular characterization of mouse intestinal tuft cells. Immuno-
fluorescent  stainings  for  (A)  SOX9  and  COX1,  (B)  SOX9  and  COX2,   
(C) HPGDS and COX1, (D) villin and COX1, (E) -tubulin and COX1, and 
(F) DCLK1 and COX1. Each panel contains a merged image on the left, 
and gray level pictures of the indicated individual markers corresponding 
to the yellow inset area on the right. (G) Whole-mount immunofluorescent 
staining for DCLK1 and F-actin on a dissociated fragment of intestinal epi-
thelium. Panels on the right show higher magnification of the cropped area 
of the overlay image. Yellow arrowheads point at tuft cells. Nuclei are 
stained with Hoechst (blue). Bars, 10 µm.JCB • VOLUME 192 • NUMBER 5 • 2011   770
epithelium,  tuft  cells  derive  from  Lgr5-expressing  intestinal 
crypt base columnar stem cells.
Differentiated tuft cells appear postnatally
The first tuft cells appear around d 7 after birth and become 
readily detectable a week later (Fig. 4). In adult mice, tuft cells 
are scattered throughout the crypt and villus epithelium, and 
represent 0.4% of all epithelial cells (Fig. S2 A). In adult ani-
mals,  representation  of  the  tuft  cell  population  is  similar 
throughout the entire length of the small and large intestines 
(Fig. S2 B). Except for SOX9, also expressed in Paneth cells, 
-galactosidase
+ tuft cells. When we quantified this, we found 
53 -galacosidase
+ tuft cells out of 10,650 -galactosidase
+ epi-
thelial cells (0.49%), and 51 -galacosidase
 tuft cells out of 
14,340 -galacosidase
 epithelial cells (0.35%). The difference 
between the two values was not significant (P = 0.23), and both 
values were close to the representation of tuft cells in wild-type 
intestinal tissue sections (0.4%; see Fig. S2 A). In addition, tuft 
cells located within a stretch of -galacosidase
+ epithelial cells 
were invariably -galacosidase
+, as shown with SOX9 (Fig. 3 B) 
and DCLK1 (Fig. 3 C) stainings. This demonstrates that, like 
the four established differentiated cytotypes of the intestinal 
Figure 2.  DCLK1-expressing tuft cells are post-mitotic and continuously renewed. (A) Immunofluorescent staining for COX1, DCLK1, PCNA, and Hoechst. 
The PCNA
 nucleus of a tuft cell is highlighted by a yellow dotted circle. (B) Experimental scheme of the BrdU birth dating experiment. Relative proportion 
and number of crypt DCLK1-expressing cells positive for BrdU are indicated. Two representative immunofluorescent stainings for DCLK1 and BrdU are 
shown for the indicated time point. Nuclei are stained with Hoechst (blue). Yellow dotted circles highlight tuft cell nuclei.771 Tuft cells: a new intestinal epithelial lineage • Gerbe et al.
tuft cells do not share expression of other markers with entero-
cytes, goblet, or enteroendocrine cells (Fig. S3), suggesting that 
they constitute a distinct differentiated cell type.
Presence of cells expressing tuft cell 
differentiation markers in intestinal tumors
Because tuft cells are the only epithelial cells expressing the 
COX1 and COX2 enzymes in the healthy intestinal epithelium, 
and these enzymes are strongly linked to intestinal tumori-
genesis (Wang and Dubois, 2010), we analyzed the status of tuft 
cells in mouse small intestinal and colon tumors originating 
from two different oncogenic initiating events. Surprisingly, tuft 
cells could still be identified in the transformed lesions of mice 
carrying a k-Ras
V12G activating mutation (Janssen et al., 2002; 
Fig. 5, A and B) or a mutation in the Adenomatosis polyposis 
coli (Apc) tumor suppressor gene (Colnot et al., 2004; Fig. 5, C–F). 
In both cases, tuft cells invariably stained negative for expres-
sion of proliferation markers such as PCNA and did not incor-
porate BrdU (Fig. 5 F). In human lesions, tuft cells were also 
found in adenomas (Fig. 5 G), but rarely in adenocarcinoma 
(Fig. 5 H). This indicates that the tuft cell differentiation path-
way is remarkably conserved in early tumor tissue, but not in 
their more malignant counterpart, raising the question of the 
potential role played by tuft cells during tumorigenesis.
The ATOH1 transcription factor is required 
for tuft cell differentiation, which identifies 
them as secretory cells
Having shown that tuft cells are differentiated and constantly 
renewed, we then asked to what extent they share the differ-
entiation pathways previously reported for enterocytes, goblet, 
Paneth, and enteroendocrine cells and, therefore, to what extent 
tuft cells are related to these four cell types. It is generally as-
sumed that commitment toward a specific differentiated cyto-
type involves the choice between one of the secretory fates 
(goblet, Paneth, or enteroendocrine cells) and the absorptive 
fate (enterocyte). This early cell fate decision is controlled by 
ATOH1 because differentiation of all secretory cell types is im-
paired in Atoh1 knock-out mice, whereas differentiation of the 
absorptive  enterocytes  is  unaffected  (Shroyer  et  al.,  2007). 
Compared with Atoh1
LoxP/LoxP or Villin-Cre
ERT2 control mice (n = 5), 
in which tuft cell representation is unchanged, the intestinal   
epithelium of tamoxifen-injected Atoh1
LoxP/LoxP; Villin-Cre
ERT2 
mice  (n  =  5)  is  completely  devoid  of  tuft  cells  (Fig.  6).   
Figure  3.  Tuft cells derive from Lgr5
+ CBC stem cells.  (A)  Scheme  ex-
plaining how chimeric Cre expression in crypts results in heterogeneous 
-galactosidase staining in the adjacent villi (several crypts contribute to 
the generation of the cells constituting each villus). Wild-type (gray) and   
-galactosidase (blue) cells coming from un-recombined (gray) and recombined 
(blue) crypts can migrate and colonize the same villus. The resulting cross sec-
tion is shown. (B) Immunofluorescent staining for SOX9, -galactosidase,   
-catenin, and Hoechst in the Lgr5
-EGFP-IRES-creERT2; Rosa26-LacZ mouse. Arrow-
heads point at SOX9
+ tuft cells. The inset shows higher magnification of a 
SOX9
+ tuft cells nucleus within a stretch of -galactosidase
+ cells. (C) Immuno-
fluorescent staining for DCLK1, -galactosidase, -catenin, and Hoechst 
in intestinal sections from the Lgr5-
EGFP-IRES-creERT2; Rosa26-LacZ mouse line.   
Arrowheads point at DCLK1
+ tuft cells. The inset shows higher magnifica-
tion of two DCLK1
+ tuft cells within -galactosidase
+ crypts. -galactosidase
- 
crypts are shown by white dotted lines. Bars, 10 µm.
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required for tuft cells. We analyzed the tuft cell population in 
the  intestinal  epithelium  of  Neurog3
LoxP/LoxP; Villin-Cre  mice   
(n = 4), in which the Neurog3 gene is constitutively deleted at 
mid-gestation in all intestinal epithelial cells, and in control 
Neurog3
LoxP/LoxP mice (n = 4). DCLK1 and chromogranin A (ChgA) 
immunohistochemical staining of sections from Neurog3-deficient 
mice and littermate controls showed that tuft cells are still pres-
ent in the absence of Neurog3, whereas no enteroendocrine cells 
are found (Fig. 7, A and B). This indicates that tuft and entero-
endocrine cells do not share the same transcription factor re-
quirements for differentiation.
Furthermore, within the crypt progenitor cell compart-
ment,  Neurog3  expression  was  restricted  to  enteroendocrine 
progenitor cells, in which SOX9 is barely detectable, in contrast 
to tuft cells where SOX9 is highly expressed (Fig. 7 C). These 
data, and the lack of evidence for an endocrine function of tuft 
cells, lead to the conclusion that tuft cells do not represent a 
subset of enteroendocrine cells.
Distinct genetic requirements for 
differentiation between tuft and Paneth or 
goblet cells
Goblet and Paneth cells share some transcription factor require-
ments  for  differentiation,  for  instance  GFI1  (Shroyer  et  al., 
2005; Bjerknes and Cheng, 2010) and SPDEF (Gregorieff et al., 
2009; Noah et al., 2010). To investigate the relationship between 
these two cell types and tuft cells, we first analyzed tuft cell dif-
ferentiation in Gfi1-deficient mice (Shroyer et al., 2005). In such 
mice (n = 5), we observed the expected increased representation 
of Neurog3
+ and/or ChgA
+ cells (Fig. S4 A), at the expense of 
goblet and Paneth cells (Shroyer et al., 2005). As previously re-
ported (Bjerknes and Cheng, 2010), we also observed de novo 
Neurog3 expression and the presence of ChgA
+ granules in 
some Gfi1-deficient lysozyme
+ Paneth cells (Fig. S4 B). In con-
trast, the tuft cell population was not affected and Neurog3 ex-
pression  was  never  detected  in  tuft  cells  (n  =  126)  from 
Gfi1-deficient mice (Fig. S4, A and B). This indicates that, un-
like Paneth and goblet cells, tuft cells do not require GFI1 to re-
press Neurog3 expression.
Second, we examined whether tuft cell differentiation   
requires SPDEF function. Similar numbers of tuft cells were 
identified after staining sections of intestine from Spdef-deficient 
and control mice (Fig. S4 C). This indicates that tuft cells can 
still differentiate in the absence of Spdef, which again distin-
guishes them from goblet and Paneth cells.
Finally, it was shown previously that the SOX9 transcription 
factor is expressed in terminally differentiated Paneth cells (Blache 
et al., 2004) and is required for their differentiation (Bastide et al., 
2007; Mori-Akiyama et al., 2007). The finding that post-mitotic tuft 
cells also express SOX9 prompted us to test whether it is required 
for their differentiation. Tamoxifen was injected to induce deletion 
of Sox9 and the mice were analyzed after various times, ranging 
from 1 wk to 4 wk after induction, the latest time corresponding to 
at least four complete renewal cycles of the intestinal epithelium. 
Independently of the time left between the tamoxifen injection and 
the analysis, tuft cells were still present in Sox9
LoxP/LoxP; Villin- 
Cre
ERT2 mice (n = 2), as evidenced by COX1 staining (Fig. 8 A),   
This conclusion was based on the analysis of several markers   
of tuft cells, including the SOX9 transcription factor and the 
COX1 enzyme (Fig. 6, A and C) and the -tubulin and DCLK1 
proteins (Fig. 6, B and D), which are related to the unique   
morphology of tuft cells. Thus, together with goblet, Paneth, 
and enteroendocrine cells, tuft cells depend on Atoh1 function 
for their differentiation and belong to a secretory lineage of the 
intestinal epithelium.
Distinct genetic requirements for 
differentiation between tuft and 
enteroendocrine cells
Tuft cells have recently been proposed to represent a subset of 
enteroendocrine  cells  (Formeister  et  al.,  2009;  Kokrashvili   
et al., 2009). To test this possibility, we checked whether 
Neurog3, a transcription factor essential for all enteroendocrine 
subtypes (Jenny et al., 2002; Mellitzer et al., 2010), is also   
Figure  4.  Tuft  cells  appear  after  birth.  Immunofluorescent  staining  for 
DCLK1 and PCNA in the developing small intestine of E18.5, P7, and P12 
mice. Arrowheads point at DCLK1-expressing tuft cells. Nuclei are stained 
with Hoechst (blue). Bars, 10 µm.773 Tuft cells: a new intestinal epithelial lineage • Gerbe et al.
Taken together, these data show that most of the well-known 
genetic factors that control differentiation of goblet and Paneth cells 
are not essential for differentiation of tuft cells, which suggests that 
tuft cells are not closely related to either of these two cell types.
and still displayed their typical villin-immunoreactive apical tuft 
(Fig. 8 B) and DCLK1 expression (not depicted). Thus, SOX9 is 
not necessary for tuft cell survival and differentiation, nor for the 
expression of the COX1 and DCLK1 proteins.
Figure 5.  Tuft cells are found in mouse and human intestinal tumors. Immunofluorescent staining for tuft cells in K-Ras
V12G mouse adenoma (A and B); 
Apc14 mouse adenoma (C–F), human adenoma (G), and human adenocarcinoma (H). Large fields (A and C) show clusters of tuft cells within the lesions. 
The lesion is delimited by PCNA (A) or -catenin staining (C). DCLK1
+ tuft cells coexpress the COX1 enzyme (B and D), show nuclear translocation of 
-catenin (E), and are not in a proliferative state (F). Using HPGDS staining, tuft cells can also be detected in human adenomas (G) and, in rare cases, in 
restricted areas of human adenocarcinomas (H). For fluorescent staining, overlay (left) and individual signals of the indicated markers (right) are shown. 
Yellow dotted circles in E highlight tuft cell nuclei. Arrowheads point at tuft cells identified by DCLK1, COX1, and HPGDS expression. Nuclei are stained 
with Hoechst (blue) or hematoxylin (G and H). Bars: (A–F) 10 µm; (G and H) 100 µm.JCB • VOLUME 192 • NUMBER 5 • 2011   774
Discussion
Intestinal tuft cells have long been refractory to functional analy-
ses, and until now could only be formally identified by electron 
microscopic analysis. In this paper we report several molecular 
markers that allow unambiguous identification of tuft cells of 
the intestinal epithelium, as well as in other organs (see Fig. S1), 
thus paving the way to their characterization.
Development of tuft cells
Tuft cells can be identified by DCLK1 expression from 1 wk 
postnatal in the mouse intestine. This is consistent with a 
study in the rat stomach, in which tuft cells are detected from 
the weaning stage (4 wk postnatal; Iseki et al., 1991). How-
ever, it cannot be excluded that immature tuft cells that do 
not  express  differentiation  markers  such  as  DCLK1  exist   
at earlier stages. For instance, tuft cells have been identi-
fied in the 20-wk-old fetal human small intestine, but their 
Tuft cells are responsible for opioid 
production by the intestinal epithelium
Endogenous opioids mediate multiple functions in the regula-
tion of the gastrointestinal mucosa physiology, including regu-
lation of gastric emptying, gut motility, intestinal secretion, and 
pain (Holzer, 2009), and their production was recently reported 
to rely on a subpopulation of enteroendocrine cells (Kokrashvili 
et al., 2009) expressing the TRPM5 ion channel, but not ChgA, a 
marker of most enteroendocrine cells. As tuft cells are some-
times considered as enteroendocrine cells, and Trpm5 expression 
has been reported in tuft cells (Bezençon et al., 2008), Kokrashvili 
et al. (2009) hypothesized that opioid-producing cells could be 
tuft cells. We tested this hypothesis using our tuft cell markers. 
Indeed, costaining of intestinal villi for -endorphin, COX1, and 
villin expression confirmed that -endorphin production is re-
stricted to tuft cells (Fig. 9). Importantly, all tuft cells express   
-endorphin (n = 70) in the intestinal epithelium, thus validating 
the first tuft cell–specific functional property identified so far.
Figure 6.  Atoh1 is required for tuft cell differentiation. Immunofluorescent staining for the SOX9 transcription factor (A and C), the COX1 enzyme (A–D), 
and for the structural- and morphological-related tuft cells markers DCLK1 and -tubulin (B and D) in intestines from control (A and B) and Atoh1-deficient 
mice (C and D), 3 wk after tamoxifen injection. Each panel contains the merged image on the left, and separate pictures of the indicated markers corre-
sponding to the yellow inset on the right. Yellow arrowheads point at tuft cells revealed by SOX9 and COX1 or DCLK1, -tubulin, and COX1 expression. 
Nuclei are stained with Hoechst (blue). Bars, 10 µm.775 Tuft cells: a new intestinal epithelial lineage • Gerbe et al.
quiescent stem cells, at least in healthy conditions. However, 
self-renewing stem cells and early differentiated precursor cell 
populations may not be sharply and definitely distinguished dur-
ing the dynamics of epithelial turnover. For instance, tracing the 
progeny of Neurog3-expressing cells with a LacZ reporter gene 
could, in some rare events, identify complete -galactosidase
+ 
crypt–villus  axes,  indicating  that  Neurog3-controlled  Cre  
DCLK1 expression status has not been analyzed (Moxey and 
Trier, 1978).
Early differentiation of tuft  
cells in crypt bottoms
In the mouse small intestine, most tuft cells are found on villi or 
near the crypt–villus junction, but some are present in intestinal 
crypts where they can be detected at virtually any position above 
the Paneth cell compartment. Even when localized in crypts, 
identifiable tuft cells are postmitotic, always express differenti-
ation markers such as DCLK1, HPGDS, and strong SOX9 ex-
pression, have elevated F-actin immunoreactivity, and display a 
gradient expression of COX1 and COX2 (exemplified for COX1 
in Fig. 8 A). The presence of DCLK1
+, COX1
low in crypt bot-
toms suggests that, like for the enteroendocrine cell lineage 
(Fig. S5 and Bjerknes and Cheng, 2006), tuft cell fate commit-
ment may occur at an early stage, in the close vicinity of or even 
within the stem cell compartment.
DCLK1, quiescent stem cells,  
and tuft cells
The fact that crypt base–located post-mitotic tuft cells express 
none of the common markers of the other, best known, lineages 
probably  explains  why  DCLK1-expressing  cells  have  previ-
ously been proposed as quiescent stem cells (Giannakis et al., 
2006; May et al., 2008, 2009; Dekaney et al., 2009; Jin et al., 
2009; Sureban et al., 2009). However, the majority of DCLK1
+ 
cells are found in the villi, not in the stem cell compartment. In 
this study we confirmed DCLK1 as a specific marker of tuft 
cells. This permanently renewed cell population with a high 
turnover rate can hardly be considered as a likely source of 
Figure 7.  Neurog3 is dispensable for tuft cell differentiation. (A and B) 
Immunofluorescent staining for DCLK1 and ChgA expression in intestines 
from 6-mo-old control or Neurog3-deficient mice. Yellow and green arrow-
heads point at tuft and enteroendocrine cells, respectively. (C) Immuno-
fluorescent staining for SOX9 and Neurog3 in wild-type mouse intestine. 
The arrowhead points at a Neurog3
+, SOX9
 cell. Nuclei are stained with 
Hoechst (blue). Bars, 10 µm.
Figure  8.  Normal  tuft  cell  differentiation  in  Sox9-deficient  intestine.  
(A) Immunofluorescent staining for SOX9 and COX1 in intestines from 
control or Sox9-deficient mice, 1 mo after the first tamoxifen injection. 
Yellow arrowheads point at tuft cells identified by SOX9 and/or COX1 
expression. The right inset shows the gray level picture of the COX1 stain-
ing, which is hardly visible in the merged image. (B) Immunofluorescent 
staining for SOX9, villin, and COX1 in the intestines of wild-type and Sox9-
deficient mice. Each panel contains the merged image on the left, and 
individual fluorescent signals of the indicated markers corresponding to the 
yellow inset on the right. Arrowheads point at tuft cells identified by SOX9 
and/or COX1 and villin expression. The tuft cell nucleus shown in the 
Sox9-deficient tissue is highlighted by the yellow circle. Nuclei are stained 
with Hoechst (blue). Bars, 10 µm.JCB • VOLUME 192 • NUMBER 5 • 2011   776
reports  included  tuft  cells  in  the  enteroendocrine  lineage 
(Formeister et al., 2009; Kokrashvili et al., 2009) prompted us 
to investigate whether one or several differentiation pathways 
are shared between enteroendocrine and tuft cells. We found 
that in contrast to the enteroendocrine cell lineage, which strictly 
depends on Neurog3 function (Jenny et al., 2002; Mellitzer   
et al., 2010), tuft cells are still produced in the absence of Neurog3. 
In addition, COX1
low tuft cells that are still in the process of   
terminal  maturation  express  high  levels  of  SOX9  and  never   
express  Neurog3,  whereas  SOX9  is  barely  detectable  in 
Neurog3-expressing enteroendocrine precursor cells (Bjerknes 
and Cheng, 2006). Tuft cells and Ngn3-dependent enteroendo-
crine cells thus constitute distinct cell types. In the future, how-
ever, it is conceivable that an endocrine type of secretion is 
demonstrated for tuft cells. In this case, they could be consid-
ered as type 2 enteroendocrine cells, which do not require Ngn3 
function for their differentiation.
Moreover,  whereas  differentiation  of  both  goblet  and   
Paneth cells is regulated by GFI1 (Shroyer et al., 2005; Bjerknes 
and Cheng, 2010) and SPDEF (Gregorieff et al., 2009; Noah 
et al., 2010), these transcription factors are not essential for 
tuft cells. In addition, Paneth cells require SOX9 function to 
differentiate (Bastide et al., 2007; Mori-Akiyama et al., 2007) 
but tuft cells, which express high levels of SOX9 in their ter-
minally differentiated state, are still present in Sox9-deficient 
intestinal epithelium.
In summary, although tuft cells are produced from the 
same Lgr5
+ stem cell as enterocytes, goblet, Paneth, and entero-
endocrine cells, we show here that they represent an indepen-
dent cell type: (i) they express a specific marker signature, and 
(ii) except for ATOH1, none of the transcription factors known 
to be required for differentiation of the other intestinal epithelial 
cell types and that we tested here is essential for tuft cell differ-
entiation (Fig. 10).
Future studies will deepen the knowledge of the lineage 
intermediates that are shared by precursors of several differenti-
ated cell types and refine the current understanding of the rela-
tionship between tuft cells and the other constituents of the 
intestinal epithelium.
Understanding the role played by tuft cells in the physio-
pathology of the intestinal epithelium is currently hampered by 
the absence of animal models specifically devoid of tuft cells. 
As previously suggested by gene profiling experiments in intes-
tinal Trpm5-expressing cells (Bezençon et al., 2008), we con-
firm here that tuft cells are the only epithelial cells in the healthy 
mucosa to express the COX1 and COX2 enzymes, whose ex-
pression is rate limiting for the biosynthesis of prostanoids. Tuft 
cells also express Hpgds and thus represent a likely epithelial 
source of prostaglandin-D2. This is important given the central 
role played by prostanoids in mediating inflammation and   
tumorigenesis in the intestinal epithelium (Stenson, 2008; Wang 
and Dubois, 2010). Indeed, the presence of tuft cell clusters in 
tumors from Apc- or K-Ras–mutated mice suggests a possible 
contribution of tuft cells during tumorigenesis. The previous 
observation that siRNA-mediated inhibition of Dclk1 expres-
sion  in  tumor  xenografts  resulted  in  reduced  tumor  growth 
(Sureban et al., 2009) further supports this notion. Finally, we 
expression occurred in pluripotent cells of the crypt, or that 
Neurog3-expressing enteroendocrine precursor cells reverted 
to  a  pluripotent  state  (Schonhoff  et  al.,  2004).  In  our  case, 
DCLK1 expression was only detected in post-mitotic cells, but 
it is not possible to definitively exclude that some early tuft 
cells that are still in the vicinity of the stem cell niche might 
have the capacity to de-differentiate and revert to a stem cell 
phenotype under stress conditions, which could potentially ex-
plain the results found by others using in vitro culture assays 
(May et al., 2009).
Tuft cells represent a fourth secretory cell 
type of the intestinal epithelium
Although tuft cells were identified 50 years ago, they have   
remained poorly characterized. As a result, the relationship   
between tuft cells and the four other cell types of the intestinal 
epithelium has remained elusive, and it is currently assumed 
that only four main differentiated cell types constitute this epi-
thelium. Studies on the lineage of intestinal epithelial cells are 
still scarce, but pioneering experiments established that multi-
potent Lgr5-expressing CBC stem cells (Barker et al., 2007) 
produce several types of intermediate bipotent or monopotent 
precursors from which enterocyte or goblet cells (Bjerknes and 
Cheng, 1999) and enteroendocrine cells (Bjerknes and Cheng, 
2006) arise. In addition, multiple gene deletion studies in mouse 
models facilitated the decoding of transcription factor require-
ments for differentiation of these four cell types, but tuft cells 
have never been considered in such studies.
Here, we evaluated the status of tuft cells in several of 
these genetically engineered mouse lines. We found that tuft 
cells are absent in Atoh1-deficient mice, which according to the 
prevalent model of intestinal epithelial differentiation (van der 
Flier and Clevers, 2009), characterizes them as a secretory cell 
type. This is consistent with their capacity to produce (Fig. 9) 
and release opioids through an exocrine–paracrine mechanism 
(Kokrashvili et al., 2009). However, the fact that previous   
Figure 9.  Tuft cells are responsible for opioid production by the intesti-
nal epithelium. Whole-mount immunofluorescent staining for -endorphin, 
COX1, and villin in dissociated fragments of villus epithelium. Arrowheads 
point at tuft cells. Nuclei are stained with Hoechst (blue). Bars, 10 µm.777 Tuft cells: a new intestinal epithelial lineage • Gerbe et al.
genetic background. For proliferation analyses, mice were injected with 
0.1 mg BrdU (Roche)/PBS per gram of mouse body weight. Mice were 
sacrificed 2 h after injection. For long-term BrdU incorporation studies, 
BrdU was given ad libitum (0.5 mg/ml) during the indicated time.
Human samples
Slides of human intestinal biopsies were kindly provided by Drs. J.-F. Bourgaux 
and C. Pignodel (Centre Hospitalier Régional Universitaire, Nîmes, France).
Fluorescent and bright-field immunohistochemistry  
on paraffin-embedded tissue
Tissue dissection, fixation, and immunohistochemistry on thin sections of 
paraffin-embedded tissue were performed essentially as described previ-
ously (Bastide et al., 2007). In brief, 5-µm-thick sections were dewaxed in 
xylene and rehydrated in graded alcohol baths. Antigen retrieval was per-
formed by boiling slides for 20 min in 10 mM sodium citrate buffer, pH 6.0. 
Nonspecific binding sites were blocked in blocking buffer (TBS, pH 7.4, 
5% dried milk, and 0.5% Triton X-100) for 60 min at RT. Sections were then 
incubated with primary antibodies diluted in blocking buffer overnight at 
4°C. Primary antibodies used in this study were as follows: anti-SOX9 
(AB5535; 1:1,000) and anti-villin (MAB1671; 1:500) were purchased 
from Millipore. Anti-COX1 (sc-1754; 1:200), anti-COX2 (sc-1747; 1:200), 
anti-PCNA (sc-56; 1:200), and anti-MUC2 (sc-15334; 1:200) were from 
Santa Cruz Biotechnology, Inc. Anti-HPGDS (160013; 1:200) was from 
Cayman Chemical. Anti–-tubulin (32–2500; 1:200) was from Invitrogen. 
Anti-Neurog3  (F25A1B3;  1:100)  was  from  the  Developmental  Studies   
Hybridoma Bank (Iowa City, IA). Anti–-catenin (610154; 1:200) was 
from BD. Anti–-endorphin (20063; 1:100) was from Immunostar. Anti-
BrdU was from Abcam (Ab1893; 1:300) or from the Developmental Stud-
ies  Hybridoma  Bank  (G3G4;  1:300).  Anti–-galactosidase  (ab9361; 
1:400) was from Abcam. Anti-lysozyme (RB-372; 1:500) was from NeoMark-
ers. Anti-DCLK1 was from Abcam (ab37994; 1:200) or Abgent (AP7219b; 
1:200). Anti-ChgA was from Immunostar (20085; 1:1,000) or Santa Cruz 
Biotechnology,  Inc.  (sc-1488;  1:400).  Anti-Ki67  (ab15580;  1:500) 
show here that tuft cells are the only intestinal epithelial cells to 
produce -endorphin in healthy conditions, and thus likely con-
tribute to the regulation of vasoconstriction, peristaltic move-
ments, and pain in the intestine.
In conclusion, we present here molecular and genetic 
evidences that tuft cells constitute a genuine fifth cell type in the 
intestinal epithelium, as well as the first insights into functions 
of these cells with their production of prostanoids and opioids. 
Further studies will determine whether tuft cells from other 
endoderm-derived epithelia share similar functions.
Materials and methods
Animals: mouse strains
The Sox9
LoxP/LoxP; Villin-Cre
ERT2 strain was obtained by mating Sox9
LoxP/LoxP 
mice (Kist et al., 2002) with Villin-Cre
ERT2 animals (el Marjou et al., 2004). 
Sox9 deletion in the intestinal epithelium was induced by a single daily   
i.p. injection of 1 mg tamoxifen (Sigma-Aldrich) for 5 d. Mice were sacri-
ficed 1 wk and 1 mo after the first tamoxifen injection. The Apc14 (Colnot 
et al., 2004), Villin-K-Ras
V12G (Janssen et al., 2002), Neurog3
LoxP/LoxP; Villin-
Cre (Mellitzer et al., 2010), Gfi1
/ (Shroyer et al., 2005), and Spdef
/ 
(Gregorieff  et  al.,  2009)  strains  have  been  described  previously.  The   
Lgr5
-EGFP-IRES-creERT2;  Rosa26-LacZ  strain  has  been  described  previously 
(Barker et al., 2007); mice were induced at 4 wk of age by a single i.p. in-
jection of tamoxifen, and were analyzed 14 or 22 mo later. Atoh1
LoxP/LoxP; 
Villin-Cre
ERT2 mice were obtained by crossing Atoh1
LoxP/LoxP (Shroyer et al., 
2007) and Villin-Cre
ERT2 animals (el Marjou et al., 2004). Atoh1 deletion 
was induced by a single daily i.p. injection of 1 mg tamoxifen (Sigma- 
Aldrich) for 4 d. Mice were sacrificed on d 5 or 22 after the first tamoxi-
fen  injection.  Wild-type  animals  used  in  this  study  had  a  C57BL/6 
Figure 10.  Updated model for the differentiation of the intestinal epithelial cell types. The scheme on the left represents a crypt–villus unit in the adult 
mouse small intestinal epithelium. The main functions, including the recently discovered function of Paneth cells in maintaining the CBC stem cell population 
(Sato et al., 2011), and representative molecular markers identifying each of the cell types and the intestinal stem cell are indicated. Opioid secretion is 
known to occur in the gut lumen (blue arrows; see Kokrashvili et al., 2009). Strong evidence suggests that tuft cells can also act as an epithelial source of 
prostanoids (Bezençon et al., 2008 and this paper), but the underlying secretion mechanism still has to be demonstrated. The diagram on the right sum-
marizes the genetic hierarchy of epithelial cell lineage commitment in the intestine. Intestinal CBC stem cells proliferate and produce progenitors. Choice 
between absorptive or secretory cell fates is under the control of the hairy/enhancer of split 1 (Hes1) or atonal homologue 1 (Atoh1) gene. Within the 
cells committed to secretory types, Neurog3 is required for enteroendocrine cell differentiation. Gfi1 is required for Paneth and goblet cell differentia-
tion, preventing the expression of Neurog3. Sox9 is essential for differentiation of Paneth cells. Spdef is required for both Paneth and goblet cell terminal 
maturation. M-cells are known to derive from Lgr5
+ CBC stem cells (Barker and Clevers, 2010), but knowledge of the molecular pathways leading to their 
differentiation is still missing.JCB • VOLUME 192 • NUMBER 5 • 2011   778
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and anti–phospho-histone H3 (ab14955; 1:800) were from Abcam. Slides 
were then washed two times with 0.1% PBS-Tween (Sigma-Aldrich) before 
incubation with fluorescent secondary antibodies conjugated with either 
Alexa 488, Cyanin-3, or Cyanin-5 (Jackson ImmunoResearch Laboratories, 
Inc.) and Hoechst at 2 µg/ml (Sigma-Aldrich) in PBS–Triton X-100 0.1% 
(Sigma-Aldrich). Stained slides were then washed two extra times in PBS 
before mounting with aqueous glycerol–mowiol medium. Methods used for 
bright-field immunohistochemistry were identical, except that slides were 
incubated with 1.5% H2O2 in methanol for 20 min and washed in PBS to 
quench endogenous peroxydase activity before antigen retrieval. Envision+ 
(Dako) was used as a secondary reagent. Signals were developed with DAB 
(Sigma-Aldrich) and a hematoxylin counterstain (DiaPath) was used. After de-
hydration, sections were mounted in Pertex (Histolab).
Whole-mount fluorescent immunohistochemistry
For some experiments, immunolabeling was performed directly on whole 
crypts or whole pieces of villus epithelium. In brief, the small intestine was 
removed, flushed with PBS, and turned inside-out on a wooden stick before 
being incubated in 10 mM DTT for 15 min at room temperature to remove 
mucus. Tissue was then incubated in cold Ca
2+/Mg
2+-free PBS containing 
10 mM EDTA for 20 min and nearly intact pieces of villus epithelium were 
recovered by gentle shaking. Cycles of incubation/shaking were repeated 
until whole crypts were obtained. Whole fragments of epithelium were 
fixed in 4% PFA for 2 h at RT and then washed twice in PBS before being 
processed for immunohistochemistry. Pieces of epithelium were first incu-
bated and permeabilized in blocking buffer (TBS, pH 7.4; 5% dried milk, 
and 0.5% Triton X-100) for 1 h at RT before incubation with primary anti-
bodies overnight. Material was then washed four times in PBS Triton X-100 
(0.1%) at RT before incubation with fluorescent-conjugated secondary anti-
bodies (Jackson ImmunoResearch Laboratories, Inc.) and Hoechst at 2 µg/ml 
(Sigma-Aldrich) for 60 min at RT in PBS Triton X-100 (0.1%). Stained tissues 
were washed two extra times in PBS, smeared in poly-lysine–coated slides, 
and mounted in glycerol–mowiol medium. F-actin staining was performed 
with Alexa Fluor 647–conjugated phalloidin (Invitrogen).
Microscopy and imaging
Fluorescent pictures were acquired at room temperature under a micro-
scope (AxioImager Z1; Carl Zeiss, Inc.), equipped with a camera (AxioCam 
MRm; Carl Zeiss, Inc.), EC Plan Neofluar (5x, NA 0.16; 10x, NA 0.3; 
20x, 0.5 NA; 100x, NA 1.3) and Plan Apochromat (40x, NA 0.95; 63x, 
NA 1.4) objectives, the Apotome Slider system equipped with an H1 trans-
mission grid (Carl Zeiss, Inc.), and AxioVision software (Carl Zeiss, Inc.). 
Aqueous mounting medium (0.1 M Tris, pH 8.5, 24% glycerol wt/vol, 
10%  mowiol  wt/vol  [Sigma-Aldrich],  and  2.5  mg.ml
1  final  DABCO 
[Sigma-Aldrich]) was used for fluorescent acquisition. Bright-field immuno-
histochemistry pictures were taken at room temperature with a microscope 
(Eclipse 80i; Nikon) with Plan Fluor (10x, NA 0.3; 20x, NA 0.5; 40x, NA 
0.75; and 60x, NA 0.5–1.25) lenses (Nikon) and a digital camera   
(Q-Imaging Retiga 2000R with a Q-Imaging RGB Slider). Pictures were 
captured with Q-Capture Pro software (Nikon). For wide-field acquisition 
of bright-field images, slides were scanned at 20x with the Nanozoomer 
Slide Scanner (Hamamatsu Photonics). Resulting images were visualized 
and annotated with NDPview software (Hamamatsu Photonics). Post-treatment 
of pictures, annotations, and panel composition were performed with 
Photoshop software (Adobe).
Statistical analyses
Histograms and determination of standard deviations were calculated with Excel 
software (Microsoft). Statistical analysis of proportions of -galactosidase
+  
tuft cells versus -galactosidase
+ epithelial cells was performed by a Mann-
Whitney test with Prism software (GraphPad Software, Inc.).
Online supplemental material
Fig. S1 shows identification of tuft cells in mouse and human tissues, using 
the tuft cell signature. Fig. S2 shows that tuft cells are found all along the 
intestinal tract. Fig. S3 shows that intestinal tuft cells do not share terminal 
differentiation markers with the other secretory cell lineages. Fig. S4 shows 
that the tuft cell population is not affected in Gfi-1– or Spdef-deficient mice. 
Fig. S5 shows early enteroendocrine cell differentiation in intestinal crypts. 
Online  supplemental  material  is  available  at  http://www.jcb.org/cgi/ 
content/full/jcb.201010127/DC1.
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